New! Peptide immunogenicity assessment software
Discover Seqtara and everything new at MultiCASE!
Regulatory-aligned in silico predictions
The MultiCASE software platform is designed to provide regulatory-aligned in silico predictions and supporting information to aid users in making informed, evidence-based risk assessments. Using our software supports global initiatives to reduce unnecessary animal testing while aiding in efforts to promote public safety. Use CASE Ultra for classical QSAR toxicity predictions, QSAR Flex to evaluate complex toxicological endpoints, and our newest program, Seqtara, for peptide sequence analysis.
CASE Ultra
classical QSAR predictions
QSAR Flex
complex toxicological endpoints
Seqtara
peptide immunogenicity evaluations
The latest presentations and publications from MultiCASE
We work with established and dependable distribution partners to support our global user base.